PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA2

Yuming Wang1,2, Yiwei Liu1,2, Hairong Chen3

  • 1Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), 300 Guangzhou Road, Nanjing, China.

Abstract

Insights

Peptidylprolyl Cis/Trans Isomerase, NIMA-Interacting 1 (PIN1) drives cholangiocarcinoma (CCA) growth and metastasis by regulating ANXA2 phosphorylation. Targeting PIN1 with all-trans retinoic acid (ATRA) shows therapeutic potential for CCA.

Area of Science:

  • Hepatobiliary Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Cholangiocarcinoma (CCA) presents a significant clinical challenge due to poor prognosis and limited treatment options.
  • The role of Peptidylprolyl Cis/Trans Isomerase, NIMA-Interacting 1 (PIN1) in CCA pathogenesis is largely unexplored.
  • Identifying novel therapeutic targets is crucial for improving outcomes in CCA patients.

Purpose of the Study:

  • To investigate the expression and function of PIN1 in cholangiocarcinoma.
  • To elucidate the molecular mechanisms by which PIN1 influences CCA progression.
  • To evaluate the therapeutic potential of targeting PIN1 in CCA.

Main Methods:

  • Assessed PIN1 expression using tissue microarrays and TCGA data.
  • Conducted in vitro and in vivo experiments to evaluate PIN1's role in CCA cell adhesion and metastasis.
  • Utilized RNA-seq, western blotting, co-immunoprecipitation, immunofluorescence, and mass spectrometry to explore downstream pathways.

Main Results:

  • PIN1 overexpression correlated with poor prognosis in CCA and promoted cell proliferation and migration.
  • PIN1 acts as an oncogene by regulating ANXA2 phosphorylation, enhancing CCA cell adhesion.
  • The PIN1/RACK1/ANXA2 complex was identified as a key mediator of CCA progression.
  • Pharmacological inhibition of PIN1 with ATRA suppressed CCA metastasis in vivo.

Conclusions:

  • The PIN1/RACK1/ANXA2 complex plays a critical role in CCA growth and metastasis.
  • Targeting PIN1 represents a promising therapeutic strategy for cholangiocarcinoma.
  • All-trans retinoic acid (ATRA) demonstrates potential as a PIN1 inhibitor for CCA treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K